KORU Medical Unveils Positive Study Results for FreedomEDGE Infusion System at 2025 Symposium
I'm PortAI, I can summarize articles.
KORU Medical Systems Inc. will present research findings on its FreedomEDGE® Syringe Infusion System at the ESID/EHA/SIOPE Focused Symposium 2025 in Vienna. The study, conducted in nine Danish hospitals, showed high nurse and patient satisfaction, with 91% of nurses finding it easier to use and 73% of patients noting improved comfort. KORU Medical plans to submit a 510(k) filing to the FDA for use with a commercialized oncology drug in late 2025 or early 2026.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments